In the present study, using Agilent 1290 infinity ultrahigh-performance liquid chromatography (UPLC) system and electrospray ionization (ESI) coupled with an Agilent 6490 triple quadrupoles (QqQ) mass spectrometer (UPLC-ESI-QqQ) for MRM analysis, we determined the N-glycosylation site occupancy of serotransferrin in the sera of the following study subject groups: (i) a CCA risk group (PDF), who were diagnosed with PDF ultrasonographically, with a current or previous history of infection with Ov [5], (ii) CCA patients, and (iii) healthy control subjects. Here, TF is linked to infection.